The September issue of The Lancet Microbe is now online:
https://www.thelancet.com/journals/lanmic/issue/current
The journal is #OpenAccess 🔓, so you are free to explore all of its content, but these hashtags offer a flavour:
#SARSCoV2 #COVID19 #Streptococcus #pneumococcus #LoaLoa #loiasis #YellowFever #metapneumovirus #vaccine #PCV #LongCovid
#openaccess #SarsCoV2 #COVID19 #streptococcus #pneumococcus #loaloa #loiasis #yellowfever #metapneumovirus #vaccine #pcv #LongCovid #oa
New research article in The Lancet Infectious Diseases>
Efficacy against pneumococcal carriage and the immunogenicity of reduced-dose (0 + 1 and 1 + 1) PCV10 and PCV13 schedules in Ho Chi Minh City, #VietNam: a parallel, single-blind, randomised controlled trial
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2823%2900061-0/fulltext
Very excited about our latest preprint. It addresses the long-standing question why #competence in #Streptococcus #pneumoniae (the #pneumococcus) is activated during #virulence and what its major role is outside of #transformation.
https://www.biorxiv.org/content/10.1101/2022.08.03.502730v1
#competence #virulence #transformation #streptococcus #pneumoniae #pneumococcus